These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1241 related items for PubMed ID: 10610182

  • 1. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y, Li H, Martin R, Mariuzza RA.
    J Mol Biol; 2000 Nov 24; 304(2):177-88. PubMed ID: 11080454
    [Abstract] [Full Text] [Related]

  • 3. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C, Link JM, Zamora A, Jacobsen H, Meza-Romero R, Offner H, Jones R, Burrows GG, Fugger L, Vandenbark AA.
    Eur J Immunol; 2004 May 24; 34(5):1251-61. PubMed ID: 15114658
    [Abstract] [Full Text] [Related]

  • 4. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M, Ristori G, D'Amato M, Buttinelli C, Falcone M, Fieschi C, Wekerle H, Pozzilli C.
    Eur J Immunol; 1993 Jun 24; 23(6):1232-9. PubMed ID: 7684682
    [Abstract] [Full Text] [Related]

  • 5. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR, Robinson ED, Segal BM, Tranquill L, Camphausen K, Albert PS, Richert JR, McFarland HF.
    J Immunol; 1994 Nov 15; 153(10):4834-44. PubMed ID: 7525716
    [Abstract] [Full Text] [Related]

  • 6. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K, Yamamura T, Yokoyama K, Chui DH, Fukui Y, Sasazuki T, Inoko H, David CS, Tabira T.
    J Clin Invest; 2000 Apr 15; 105(7):977-84. PubMed ID: 10841661
    [Abstract] [Full Text] [Related]

  • 7. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S.
    Neuroscientist; 2009 Jun 15; 15(3):225-31. PubMed ID: 19297658
    [Abstract] [Full Text] [Related]

  • 8. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G.
    J Clin Invest; 1993 Dec 15; 92(6):2633-43. PubMed ID: 7504690
    [Abstract] [Full Text] [Related]

  • 9. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA.
    Nature; 1990 Jul 12; 346(6280):183-7. PubMed ID: 1694970
    [Abstract] [Full Text] [Related]

  • 10. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK, Henderikx P, Vainiene M, Whitham R, Bourdette D, Chou CH, Hashim G, Offner H, Vandenbark AA.
    J Neurosci Res; 1991 Feb 12; 28(2):280-90. PubMed ID: 1709690
    [Abstract] [Full Text] [Related]

  • 11. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
    Zipp F, Weber F, Huber S, Sotgiu S, Czlonkowska A, Holler E, Albert E, Weiss EH, Wekerle H, Hohlfeld R.
    Ann Neurol; 1995 Nov 12; 38(5):723-30. PubMed ID: 7486863
    [Abstract] [Full Text] [Related]

  • 12. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN, Chou YK, Whitham RH, Buckner J, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA.
    J Immunol; 1998 Jul 15; 161(2):1034-44. PubMed ID: 9670985
    [Abstract] [Full Text] [Related]

  • 13. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L.
    J Clin Invest; 1993 Feb 15; 91(2):616-28. PubMed ID: 7679413
    [Abstract] [Full Text] [Related]

  • 14. Multiple sclerosis: MHC associations and therapeutic implications.
    Holmes S, Friese MA, Siebold C, Jones EY, Bell J, Fugger L.
    Expert Rev Mol Med; 2005 Feb 14; 7(3):1-17. PubMed ID: 15710050
    [Abstract] [Full Text] [Related]

  • 15. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
    Joshi N, Usuku K, Hauser SL.
    Ann Neurol; 1993 Sep 14; 34(3):385-93. PubMed ID: 7689820
    [Abstract] [Full Text] [Related]

  • 16. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
    Vergelli M, Hemmer B, Utz U, Vogt A, Kalbus M, Tranquill L, Conlon P, Ling N, Steinman L, McFarland HF, Martin R.
    Eur J Immunol; 1996 Nov 14; 26(11):2624-34. PubMed ID: 8921948
    [Abstract] [Full Text] [Related]

  • 17. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
    Mangalam A, Rodriguez M, David C.
    Eur J Immunol; 2006 Dec 14; 36(12):3356-70. PubMed ID: 17125142
    [Abstract] [Full Text] [Related]

  • 18. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M, Wucherpfennig KW, Cannella B, Hansen BE, Svejgaard A, Pyrdol J, Ditzel H, Raine C, Engberg J, Fugger L.
    J Exp Med; 2000 Apr 17; 191(8):1395-412. PubMed ID: 10770805
    [Abstract] [Full Text] [Related]

  • 19. Modelling multiple sclerosis.
    Ebers G.
    Nat Genet; 1999 Nov 17; 23(3):258-9. PubMed ID: 10545935
    [No Abstract] [Full Text] [Related]

  • 20. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK, Culbertson N, Rich C, LaTocha D, Buenafe AC, Huan J, Link J, Wands JM, Born WK, Offner H, Bourdette DN, Burrows GG, Vandenbark AA.
    J Neurosci Res; 2004 Sep 01; 77(5):670-80. PubMed ID: 15352213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.